In a recently published article in Nature Communications entitled “Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19“, co-author Nicholas Reynolds, fellow at the the La Trobe institute for Molecular Science in Melbourne, Australia, talks with Jan about the similarity between brain effects of long-term COVID and amyloid aggregates in Parkinson’s and Alzheimer’s patients. Their early basic-science studies could lead to better understanding and potential treatments.
A lay-person summary of their research can be found at the Institute for Public Accuracy.
Did you enjoy this story? Your funding makes great, local journalism like this possible. Donate here
Leave a Reply